Mark R Albertini Selected Research

Mark R Albertini Research Topics

Disease

34	Melanoma (Melanoma, Malignant) 01/2021 - 07/2003
19	Neoplasms (Cancer) 01/2022 - 06/2003
4	Hypotension (Low Blood Pressure) 12/2012 - 11/2004
3	Lymphocytosis 12/2012 - 11/2004
3	Neuroblastoma 11/2010 - 03/2006
3	Hypersensitivity (Allergy) 11/2010 - 07/2006
2	Exanthema (Rash) 01/2021 - 11/2010
2	Uveal melanoma 03/2017 - 06/2014
2	Disease Progression 06/2014 - 06/2012
2	Residual Neoplasm 12/2012 - 07/2009
2	Hypoxia (Hypoxemia) 11/2010 - 11/2004
2	Pain (Aches) 11/2010 - 07/2006
2	Hyperbilirubinemia 11/2010 - 11/2004
1	Body Remains 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Carcinoma (Carcinomatosis) 01/2019
1	Lymphatic Metastasis 01/2016
1	Necrosis 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 03/2013
1	Renal Insufficiency (Renal Failure) 12/2012
1	Oliguria 12/2012
1	Chills 06/2012
1	Nausea 06/2012
1	Hemangiosarcoma (Angiosarcoma) 06/2012
1	Vomiting 06/2012
1	Testicular Neoplasms (Testicular Cancer) 10/2007
1	Experimental Melanoma 02/2007
1	Sarcoma (Soft Tissue Sarcoma) 07/2006

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 01/2020 - 07/2004
8	lorukafusp alfaIBA 01/2021 - 11/2004
7	Monoclonal AntibodiesIBA 06/2012 - 06/2003
4	IpilimumabIBA 01/2021 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 08/2017 - 07/2003
4	Interleukin-2 (IL2)IBA 11/2010 - 03/2006
3	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2022 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	VaccinesIBA 12/2020 - 02/2009
3	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2019
3	Thioguanine (Tioguanine)FDA Link 01/2020 - 12/2008
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2016 - 07/2004
2	InterferonsIBA 01/2021 - 03/2017
2	AZD 6244IBA 03/2017 - 06/2014
2	GlycolipidsIBA 01/2016 - 01/2010
2	Transaminases (Aminotransferases)IBA 11/2010 - 11/2004
2	Proteins (Proteins, Gene)FDA Link 11/2010 - 06/2003
2	Dopamine (Intropin)FDA LinkGeneric 11/2010 - 03/2006
2	EpitopesIBA 01/2010 - 02/2009
2	CytokinesIBA 02/2009 - 06/2003
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2008 - 10/2005
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 03/2006 - 11/2004
1	Capsules (Microcapsules)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	alpha-beta T-Cell Antigen Receptors (T-Cell Receptor alpha-Chain)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Interferon alpha-2 (Roferon-A)FDA Link 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	NivolumabIBA 01/2018
1	DNA VaccinesIBA 08/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 08/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2017
1	Temozolomide (Temodar)FDA LinkGeneric 06/2014
1	Dacarbazine (DIC)FDA LinkGeneric 06/2014
1	Adenosine Triphosphate (ATP)IBA 06/2014
1	Mitogen-Activated Protein KinasesIBA 06/2014
1	HeterochromatinIBA 03/2013
1	Phosphotransferases (Kinase)IBA 03/2013
1	C-Reactive ProteinIBA 12/2012
1	IntegrinsIBA 06/2012
1	intetumumabIBA 06/2012
1	Indicators and Reagents (Reagents)IBA 02/2011
1	AcidsIBA 02/2011
1	Melanoma-Specific AntigensIBA 02/2011
1	Immunoglobulins (Immunoglobulin)IBA 01/2010
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2009
1	Protein Subunit VaccinesIBA 02/2009
1	Interferon-alpha2bIBA 02/2009
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 12/2008
1	Sorafenib (BAY 43-9006)FDA Link 08/2008
1	Carboplatin (JM8)FDA LinkGeneric 08/2008
1	Immunoglobulin G (IgG)IBA 10/2007
1	AutoantigensIBA 02/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2007
1	Peptides (Polypeptides)IBA 01/2007
1	AntibodiesIBA 07/2006

Therapy/Procedure

13	Therapeutics 01/2021 - 10/2005
8	Immunotherapy 11/2020 - 07/2004
3	Injections 01/2021 - 01/2010
3	Drug Therapy (Chemotherapy) 03/2017 - 03/2013
2	Radiotherapy 01/2021 - 01/2021
1	Transplantation 01/2022
1	Precision Medicine 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Chemoprevention 01/2019
1	Intravenous Infusions 12/2012
1	Drug Tapering 12/2012